When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MRK - Aravive Biologics: Pipeline-In-A-Pill In Oncology
Merck & Company Inc.
Aravive is drugging the GAS6-AXL pathway to develop new medicines across several cancer indications.
Early clinical data has established safety for the company's lead drug candidate, AVB-500, and early efficacy signals in platinum-resistance ovarian cancer.
AVB-500 has the potential to be combined with other cancer drugs and expand to several indications, impacting thousands of patients worth billions of dollars.